Showing results (221-230 of 265) with videos related to
Sort By:
Pageof 27
Plants (Basel, Switzerland)|September 28, 2024
Enhanced Antioxidant, Antifungal, and Herbicidal Activities through Bioconversion of Diosgenin by Yarrowia lipolytica P01aChristian Hernández-Guzmán, Luis G Hernández-Montiel, Adrian E Velázquez-Lizarraga, et al.Revista Espanola De Cirugia Ortopedica Y Traumatologia|June 24, 2017
Necrotizing fasciitis attended in the Emergency Department in a tertiary Hospital: Evaluation of the LRINEC scaleJ R Ballesteros-Betancourt, R García-Tarriño, J Ríos-Guillermo, et al.BMC Zoology|October 10, 2024
Regeneration of the caudal fin of the evolutionary ancient tropical gar Atractosteus tropicusAlberto J Ríos-Flores, Sandra López-Flores, Jose A Martínez-Moreno, et al.The Journal of Antimicrobial Chemotherapy|June 24, 2008
Efficacy of pegylated interferon and ribavirin for retreatment of chronic HCV infection in HIV co-infected patients failing a previous standard interferon-based regimenManuel Crespo, José A Mira, Juan A Pineda, et al.BJOG : an International Journal of Obstetrics and Gynaecology|March 31, 2016
Vaginal progesterone as maintenance treatment after an episode of preterm labour (PROMISE) study: a multicentre, double-blind, randomised, placebo-controlled trialM Palacio, T Cobo, E Antolín, et al.AIDS (London, England)|May 6, 2008
Baseline serum low-density lipoprotein cholesterol levels predict response to hepatitis C virus therapy in HIV/hepatitis C virus coinfected patientsJosé del Valle, José A Mira, Ignacio de los Santos, et al.HIV Clinical Trials|February 16, 2018
Paritaprevir/ritonavir/ombitasvir plus dasabuvir in HIV/HCV-coinfected patients with genotype 1 in real-life practiceJuan A Pineda, Antonio Rivero-Juárez, Ignacio de Los Santos, et al.Bioresource Technology|December 12, 2022
Advances in process design, techno-economic assessment and environmental aspects for hydrothermal pretreatment in the fractionation of biomass under biorefinery conceptHéctor A Ruiz, William Gustavo Sganzerla, Valeria Larnaudie, et al.AIDS Patient Care and Stds|June 22, 2011
Liver toxicity of antiretroviral combinations including fosamprenavir plus ritonavir 1400/100 mg once daily in HIV/hepatitis C virus-coinfected patientsNicolás Merchante, Luis F López-Cortés, Marcial Delgado-Fernández, et al.BMC Infectious Diseases|March 2, 2019
Effectiveness and safety of dual therapy with rilpivirine and boosted darunavir in treatment-experienced patients with advanced HIV infection: a preliminary 24 week analysis (RIDAR study)Juan Pasquau, Samantha E de Jesus, Piedad Arazo, et al.Pageof 27